The pharmacology of anaesthetics in the neonate

Best Practice and Research: Clinical Anaesthesiology

Volumn 24, Issue 3, 2010, Pages 419-431

  Anderson, Brian J ^a   Allegaert, Karel ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Anaesthesia; Developmental pharmacology; Neonate; Paediatrics; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ALBUMIN; ANESTHETIC AGENT; ATRACURIUM; BUPIVACAINE; CHLOROPROCAINE; DEXMEDETOMIDINE; FENTANYL; HALOTHANE; IBUPROFEN; LEVOBUPIVACAINE; METHOHEXITAL; MIDAZOLAM; MILRINONE; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OROSOMUCOID; PROPOFOL; REMIFENTANIL; ROPIVACAINE; THEOPHYLLINE; THIOPENTAL; TRAMADOL; PLASMA PROTEIN;

ANESTHESIA LEVEL; ARTICLE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG SAFETY; GESTATIONAL AGE; HUMAN; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEUROMUSCULAR FUNCTION; NEWBORN; NEWBORN ANESTHESIA; PAIN ASSESSMENT; PATIENT MONITORING; PEDIATRIC ANESTHESIA; PHARMACODYNAMICS; PHARMACOGENOMICS; PRIORITY JOURNAL; SEDATION; BLOOD BRAIN BARRIER; BLOOD FLOW; BODY COMPOSITION; LIVER; METABOLIC CLEARANCE RATE; METABOLISM; REVIEW;

ANESTHETICS; BLOOD PROTEINS; BLOOD-BRAIN BARRIER; BODY COMPOSITION; HUMANS; INFANT, NEWBORN; LIVER; METABOLIC CLEARANCE RATE; REGIONAL BLOOD FLOW;

EID: 79951598206     PISSN: 15216896     EISSN: 1532169X     Source Type: Journal    
DOI: 10.1016/j.bpa.2010.02.019     Document Type: Article

References (89)

1. Grand RJ,Watkins JB & Torti FM. Development of the human intestinal tract: a review. Gastroenterology 1976; 70: 790-810.
2. Liang J, Co E, Zhang M et al. Development of gastric slow waves in preterm infants measured by electrogastrography. The American Journal of Physiology 1998; 274(3 Pt 1): G503-G508. (Pubitemid 28160548)
3. Anderson BJ, van Lingen RA, Hansen TG et al. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis. Anesthesiology 2002; 96(6): 1336-1345. (Pubitemid 34587201)
4. van Hoogdalem E, de Boer AG & Breimer DD. Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs. Clinical Pharmacokinetics 1991; 21(1): 11-26.
5. Taddio A, Stevens B, Craig K et al. Efficacy and safety of lidocaineeprilocaine cream for pain during circumcision. The New England Journal of Medicine 1997; 336(17): 1197-1201. (Pubitemid 27183648)
6. Salanitre E & Rackow H. The pulmonary exchange of nitrous oxide and halothane in infants and children. Anesthesiology 1969; 30: 388-394.
7. Lerman J. Pharmacology of inhalational anaesthetics in infants and children. Paediatric Anaesthesia 1992; 2: 191-203.
8. Malviya S & Lerman J. The blood/gas solubilities of sevoflurane, isoflurane, halothane, and serum constituent concentrations in neonates and adults. Anesthesiology 1990; 72(5): 793-796. (Pubitemid 20149209)
9. Friis-Hansen B. Body water compartments in children: changes during growth and related changes in body composition. Pediatrics 1961; 28: 169-181.
10. Johnson KL, Erickson JP, Holley FO & Scott JC. Fentanyl pharmacokinetics in the paediatric population. Anesthesiology 1984; 61: A441.
11. Luz G, Innerhofer P, Bachmann B et al. Bupivacaine plasma concentrations during continuous epidural anesthesia in infants and children. Anesthesia and Analgesia 1996; 82(2): 231-234. (Pubitemid 26055006)
12. Luz G, Wieser C, Innerhofer P et al. Free and total bupivacaine plasma concentrations after continuous epidural anaesthesia in infants and children. Paediatric Anaesthesia 1998; 8(6): 473-478. (Pubitemid 28523407)
13. Erichsen CJ, Sjovall J, Kehlet H et al. Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief. Anesthesiology 1996; 84(4): 834-842. (Pubitemid 26105246)
14. Anderson BJ, McKee AD & Holford NH. Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clinical Pharmacokinetics 1997; 33(5): 313-327. (Pubitemid 27480936)
15. Bosenberg AT, Thomas J, Cronje L et al. Pharmacokinetics and efficacy of ropivacaine for continuous epidural infusion in neonates and infants. Paediatric Anaesthesia 2005; 15(9): 739-749. (Pubitemid 43960890)
16. Russo H & Bressolle F. Pharmacodynamics and pharmacokinetics of thiopental. Clinical Pharmacokinetics 1998; 35(2): 95-134. (Pubitemid 28379424)
17. Bjorkman S. Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs. British Journal of Clinical Pharmacology 2005; 59(6): 691-704. (Pubitemid 40835503)
18. Johnson TN, Tucker GT, Tanner MS & Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: a metaanalysis. Liver Transplantation 2005; 11(12): 1481-1493. (Pubitemid 43072624)
19. Way WL, Costley EC & Way EL. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clinical Pharmacology and Therapeutics 1965; 6: 454-461.
20. Pokela ML, Olkkola KT, Seppala T & Koivisto M. Age-related morphine kinetics in infants. Developmental Pharmacology and Therapeutics 1993; 20(1-2): 26-34. (Pubitemid 24169492)
21. Lynn AM, Nespeca MK, Opheim KE & Slattery JT. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesthesia and Analgesia 1993; 77(4): 695-701. (Pubitemid 23291882)
22. Engelhardt B. Development of the bloodebrain barrier. Cell Tissue Research 2003; 314(1): 119-129.
23. Henthorn TK, Liu Y, Mahapatro M & Ng KY. Active transport of fentanyl by the bloodebrain barrier. The Journal of Pharmacology and Experimental Therapeutics 1999; 289(2): 1084-1089. (Pubitemid 29191270)
24. Hamabe W, Maeda T, Kiguchi N et al. Negative relationship between morphine analgesia and P-glycoprotein expression levels in the brain. Journal of Pharmacological Sciences 2007; 105(4): 353-360.
25. Choudhuri S & Klaassen CD. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. International Journal of Toxicology 2006; 25(4): 231-259. (Pubitemid 44034685)
26. Hines RN & McCarver DG. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. The Journal of Pharmacology and Experimental Therapeutics 2002; 300(2): 355-360. (Pubitemid 34106223)
27. Koukouritaki SB, Manro JR, Marsh SA et al. Developmental expression of human hepatic CYP2C9 and CYP2C19. The Journal of Pharmacology and Experimental Therapeutics 2004; 308(3): 965-974 [Epub 2003 Nov 21]. (Pubitemid 38263972)
28. Johnsrud EK, Koukouritaki SB, Divakaran K et al. Human hepatic CYP2-1 expression during development. The Journal of Pharmacology and Experimental Therapeutics 2003; 307(1): 402-407. (Pubitemid 37151933)
29. Kearns GL, Abdel-Rahman SM, Alander SW et al. Developmental pharmacologyedrug disposition, action, and therapy in infants and children. The New England Journal of Medicine 2003; 349(12): 1157-1167. (Pubitemid 37122329)
30. Berde C. Convulsions associated with pediatric regional anesthesia. Anesthesia and Analgesia 1992; 75: 164-166.
31. Anderson BJ & Hansen TG. Getting the best from pediatric pharmacokinetic data. Paediatric Anaesthesia 2004; 14(9): 713-715. (Pubitemid 39223081)
32. Chalkiadis GA & Anderson BJ. Age and size are the major covariates for prediction of levobupivacaine clearance in children. Paediatric Anaesthesia 2006; 16(3): 275-282.
33. Allegaert K, Anderson BJ, Verbesselt R et al. Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P450 2D6 activity. British Journal of Anaesthesia 2005: 231-239. (Pubitemid 41487151)
34. de Wildt SN, Kearns GL, Leeder JS & van den Anker JN. Cytochrome P450 3A: ontogeny and drug disposition. Clinical Pharmacokinetics 1999; 37(6): 485-505. (Pubitemid 30032252)
35. McCarver DG & Hines RN. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. The Journal of Pharmacology and Experimental Therapeutics 2002; 300(2): 361-366. (Pubitemid 34106224)
36. Anderson BJ & Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annual Review of Pharmacology and Toxicology 2008; 48: 303-332. (Pubitemid 351738156)
37. Anderson BJ & Holford NH. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metabolism and Pharmacokinetics 2009; 24(1): 25-36.
38. Bouwmeester NJ, Anderson BJ, Tibboel D & Holford NH. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. British Journal of Anaesthesia 2004; 92(2): 208-217. (Pubitemid 38159658)
39. Anand KJ, Anderson BJ, Holford NH et al. Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. British Journal of Anaesthesia 2008; 101(5): 680-689.
40. Anderson BJ, Woollard GA & Holford NH. A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. British Journal of Clinical Pharmacology 2000; 50(2): 125-134. (Pubitemid 30612030)
41. Anderson BJ, Pons G, Autret-Leca E et al. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Paediatric Anaesthesia 2005; 15(4): 282-292. (Pubitemid 40462802)
42. Potts AL, Warman GR & Anderson BJ. Dexmedetomidine disposition in children: a population analysis. Paediatric Anaesthesia 2008; 18(8): 722-730. (Pubitemid 352000581)
43. Allegaert K, Peeters MY, Verbesselt R et al. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. British Journal of Anaesthesia 2007; 99(6): 864-870. (Pubitemid 351773375)
44. Allegaert K, Vancraeynest J, Rayyan M et al. Urinary propofol metabolites in early life after single intravenous bolus. British Journal of Anaesthesia 2008; 101(6): 827-831.
45. Lynn A, Nespeca MK, Bratton SL et al. Clearance of morphine in postoperative infants during intravenous infusion: the influence of age and surgery. Anesthesia and Analgesia 1998; 86(5): 958-963. (Pubitemid 28198858)
46. Peters JW, Anderson BJ, Simons SH et al. Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates. Intensive Care Medicine 2005; 31(2): 257-263. (Pubitemid 40362275)
47. Rigby-Jones AE, Nolan JA, Priston MJ et al. Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit. Anesthesiology 2002; 97(6): 1393-1400. (Pubitemid 35417436)
48. Rigby-Jones AE, Priston MJ, Thorne GC et al. Population pharmacokinetics of remifentanil in critically ill post cardiac neonates, infants and children. British Journal of Anaesthesia 2005; 95: 578P-579P.
49. Minto CF, Schnider TW, Egan TD et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997; 86(1): 10-23. (Pubitemid 27043998)
50. Ross AK, Davis PJ, Dear Gd GL et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesthesia and Analgesia 2001; 93(6): 1393-1401. (Pubitemid 33111659)
51. Kan RE, Hughes SC, Rosen MA et al. Intravenous remifentanil: placental transfer, maternal and neonatal effects. Anesthesiology 1998; 88(6): 1467-1474. (Pubitemid 28283777)
52. Egan TD. Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000. Current Opinion in Anaesthesiology 2000; 13(4): 449-455. (Pubitemid 30623804)
53. Zsigmond EK & Downs JR. Plasma cholinesterase activity in newborns and infants. Canadian Anaesthetists' Society Journal 1971; 18(3): 278-285.
54. Sawyer DC, Eger 2nd EI, Bahlman SH et al. Concentration dependence of hepatic halothane metabolism. Anesthesiology 1971; 34(3): 230-235.
55. Rhodin MM, Anderson BJ, Peters AM et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatric Nephrology 2009; 24(1): 67-76.
56. Langhendries JP, Battisti O, Bertrand JM et al. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit. Biology of the Neonate 1998; 74(5): 351-362. (Pubitemid 28461753)
57. McNamara DG, Nixon GM & Anderson BJ. Methylxanthines for the treatment of apnea associated with bronchiolitis and anesthesia. Paediatric Anaesthesia 2004; 14(7): 541-550. (Pubitemid 38869920)
58. Paradisis M, Jiang X, McLachlan AJ et al. Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. Archives of Disease in Childhood 2007; 92(3): F204-F209. (Pubitemid 46698118)
59. Fisher DM, O'Keeffe C, Stanski DR et al. Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 1982; 57(3): 203-208. (Pubitemid 12057041)
60. Allegaert K, Cossey V, Debeer A et al. The impact of ibuprofen on renal clearance in preterm infants is independent of the gestational age. Pediatric Nephrology 2005; 20(6): 740-743. (Pubitemid 40663155)
61. Allegaert K, Cossey V, Langhendries JP et al. Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life. Biology of the Neonate 2004; 86(3): 207-211. (Pubitemid 39370289)
62. Stephenson T. How children's responses to drugs differ from adults. British Journal of Clinical Pharmacology 2005; 59(6): 670-673. (Pubitemid 40835499)
63. LeDez KM & Lerman J. The minimum alveolar concentration (MAC) of isoflurane in preterm neonates. Anesthesiology 1987; 67(3): 301-307. (Pubitemid 18077407)
64. Lerman J, Robinson S, Willis MM & Gregory GA. Anesthetic requirements for halothane in young children 0-1 month and 1-6 months of age. Anesthesiology 1983; 59(5): 421-424. (Pubitemid 14227515)
65. Koch SC, Fitzgerald M & Hathway GJ. Midazolam potentiates nociceptive behavior, sensitizes cutaneous reflexes, and is devoid of sedative action in neonatal rats. Anesthesiology 2008; 108(1): 122-129.
66. Tobin JR. Paradoxical effects of midazolam in the very young. Anesthesiology 2008; 108(1): 6-7.
67. Meakin G, Morton RH & Wareham AC. Age-dependent variation in response to tubocurarine in the isolated rat diaphragm. British Journal of Anaesthesia 1992; 68(2): 161-163.
68. Wareham AC, Morton RH & Meakin GH. Low quantal content of the endplate potential reduces safety factor for neuromuscular transmission in the diaphragm of the newborn rat. British Journal of Anaesthesia 1994; 72(2): 205-209. (Pubitemid 24054342)
69. Steinberg C & Notterman DA. Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors. Clinical Pharmacokinetics 1994; 27(5): 345-367. (Pubitemid 24342116)
70. Seri I, Tulassay T, Kiszel J et al. Cardiovascular response to dopamine in hypotensive preterm neonates with severe hyaline membrane disease. European Journal of Pediatrics 1984; 142(1): 3-9. (Pubitemid 14175036)
71. Cuevas L, Yeh TF, John EG et al. The effect of low-dose dopamine infusion on cardiopulmonary and renal status in premature newborns with respiratory distress syndrome. American Journal of Diseases of Children 1991; 145(7): 799-803.
72. Seri I, Tulassay T, Kiszel J et al. Effect of low-dose dopamine infusion on prolactin and thyrotropin secretion in preterm infants with hyaline membrane disease. Biology of the Neonate 1985; 47(6): 317-322. (Pubitemid 15042852)
73. Seri I. Dopamine and natriuresis. Mechanism of action and developmental aspects. American Journal of Hypertension 1990; 3(6 Pt 2): 82S-86S. (Pubitemid 20380230)
74. Arnold JH, Truog RD, Scavone JM & Fenton T. Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. The Journal of Pediatrics 1991; 119(4): 639-643.
75. Sheiner LB. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metabolism Reviews 1984; 15(1-2): 153-171. (Pubitemid 14123936)
76. Sheiner LB, Stanski DR, Vozeh S et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to D-tubocurarine. Clinical Pharmacology and Therapeutics 1979; 25(3): 358-371. (Pubitemid 9164953)
77. Anderson BJ, Allegaert K & Holford NH. Population clinical pharmacology of children: general principles. European Journal of Pediatrics 2006; 165(11): 741-746. (Pubitemid 44440510)
78. Anderson BJ, Allegaert K & Holford NH. Population clinical pharmacology of children: modelling covariate effects. European Journal of Pediatrics 2006; 165(12): 819-829. (Pubitemid 44627767)
79. Johnson TN. The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 2003; 192(1): 37-48. (Pubitemid 37153342)
80. Edginton AN, Schmitt W, Voith B & Willmann S. A mechanistic approach for the scaling of clearance in children. Clinical Pharmacokinetics 2006; 45(7): 683-704. (Pubitemid 43990570)
81. Johnson TN, Tucker GT & Rostami-Hodjegan A. Development of CYP2D6 and CYP3A4 in the first year of life. Clinical Pharmacology and Therapeutics 2008; 83(5): 670-671. (Pubitemid 351556011)
82. Bjorkman S. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children: how accurate are available scaling methods? Clinical Pharmacokinetics 2006; 45(1): 1-11. (Pubitemid 43145012)
83. Davidson AJ. Measuring anesthesia in children using the EEG. Paediatric Anesthesia 2006; 16(4): 374-387.
84. Davidson AJ, Huang GH, Rebmann CS & Ellery C. Performance of entropy and bispectral index as measures of anaesthesia effect in children of different ages. British Journal of Anaesthesia 2005; 95(5): 674-679. (Pubitemid 41600031)
85. Davidson AJ, Sale SM, Wong C et al. The electroencephalograph during anesthesia and emergence in infants and children. Paediatric Anaesthesia 2008; 18(1): 60-70. (Pubitemid 350264591)
86. Jeleazcov C, Schmidt J, Schmitz B et al. EEG variables as measures of arousal during propofol anaesthesia for general surgery in children: rational selection and age dependence. British Journal of Anaesthesia 2007; 99(6): 845-854. (Pubitemid 351773370)
87. Peeters MY, Prins SA, Knibbe CA et al. Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery. Anesthesiology 2006; 104(3): 466-474.
88. Allegaert K, van den Anker JN, de Hoon JN et al. Covariates of tramadol disposition in the first months of life. British Journal of Anaesthesia 2008; 100(4): 525-532. (Pubitemid 351773612)
89. Allegaert K, de Hoon J, Verbesselt R et al. Maturational pharmacokinetics of single intravenous bolus of propofol. Paediatric Anaesthesia 2007; 17(11): 1028-1034. (Pubitemid 47481127)